Jeil Pharmaceutical Co.,Ltd (KRX: 271980)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,900
+430 (3.45%)
Nov 18, 2024, 3:30 PM KST
-18.35%
Market Cap 187.97B
Revenue (ttm) 700.47B
Net Income (ttm) -35.74B
Shares Out 14.57M
EPS (ttm) -2,453.00
PE Ratio n/a
Forward PE n/a
Dividend 50.00 (0.40%)
Ex-Dividend Date Dec 27, 2024
Volume 11,409
Open 12,610
Previous Close 12,470
Day's Range 12,480 - 12,900
52-Week Range 12,140 - 19,870
Beta 1.12
Analysts n/a
Price Target n/a
Earnings Date Nov 10, 2024

About Jeil Pharmaceutical Co.,Ltd

Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1959
Employees 967
Stock Exchange Korea Stock Exchange
Ticker Symbol 271980
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.